67% of the people with type 2 diabetes in India also live with obesity.1 The campaign seeks to educate people with diabetes, their caregivers, and doctors about the importance of managing weight in type 2 diabetes It will further engage healthcare professionals via
Semaglutide, a GLP-1 receptor analogue (GLP-1 RA), indicated for the management of type 2 diabetes has been developed in an oral formulation for the first time. Oral semaglutide will be a gamechanger for people with type 2 diabetes who prefer oral medications over injections. was
